Comorbidity of opioid-related and anxiety-related symptoms and disorders
- PMID: 30711906
- PMCID: PMC6609499
- DOI: 10.1016/j.copsyc.2018.12.020
Comorbidity of opioid-related and anxiety-related symptoms and disorders
Abstract
Opioid use disorder and anxiety disorders co-occur at strikingly high rates, and this comorbidity is marked by a more severe clinical presentation and poorer prognosis for treatment. Given the substantial morbidity and mortality associated with these two disorders, it is imperative to understand factors related to the high rates of co-occurrence in order to inform the development of specialized treatments for this population. Several lines of study suggest that simultaneously addressing opioid-related and anxiety-related symptoms and processes, particularly intolerance of distress and pain-related anxiety, may yield improved outcomes for this high risk, vulnerable population. Future work is needed to identify other novel mechanisms as well as develop specialized treatments to augment standard medication-assisted treatment.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Similar articles
-
Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder.Addict Behav. 2018 Feb;77:225-231. doi: 10.1016/j.addbeh.2017.10.012. Epub 2017 Oct 18. Addict Behav. 2018. PMID: 29078148
-
Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review.Gen Hosp Psychiatry. 2019 Jul-Aug;59:37-50. doi: 10.1016/j.genhosppsych.2019.04.008. Epub 2019 Apr 25. Gen Hosp Psychiatry. 2019. PMID: 31141759
-
Clinical correlates of prescription opioid analgesic use in pregnancy.Matern Child Health J. 2015 Mar;19(3):548-56. doi: 10.1007/s10995-014-1536-6. Matern Child Health J. 2015. PMID: 24951127 Free PMC article.
-
Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.Psychol Med. 2012 Jun;42(6):1261-72. doi: 10.1017/S0033291711002145. Epub 2011 Oct 17. Psychol Med. 2012. PMID: 21999943 Free PMC article.
-
Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art.Depress Anxiety. 2009;26(10):888-901. doi: 10.1002/da.20600. Depress Anxiety. 2009. PMID: 19691031 Review.
Cited by
-
Oral fentanyl consumption and withdrawal impairs fear extinction learning and enhances basolateral amygdala principal neuron excitatory-inhibitory balance in male and female mice.Addict Neurosci. 2024 Dec;13:100182. doi: 10.1016/j.addicn.2024.100182. Epub 2024 Oct 15. Addict Neurosci. 2024. PMID: 39742087 Free PMC article.
-
Access to Mental Health and Substance Use Treatment in Comprehensive Primary Care Plus.JAMA Netw Open. 2024 Apr 1;7(4):e248519. doi: 10.1001/jamanetworkopen.2024.8519. JAMA Netw Open. 2024. PMID: 38669019 Free PMC article.
-
Substance Use and Anxiety About Pain Among Patients Seeking Abortion Services.Cureus. 2024 Mar 27;16(3):e57034. doi: 10.7759/cureus.57034. eCollection 2024 Mar. Cureus. 2024. PMID: 38681459 Free PMC article.
-
Prevalence and Temporal Trends of Mental Disorders in Persons with Opioid Use Disorder and Concurrent Mental Disorders in British Columbia, Canada, Using Population-Level Administrative Data, 2013 to 2021: Prévalence et tendances temporelles des troubles mentaux chez les personnes souffrant d'un trouble lié à la consommation d'opioïdes et de troubles mentaux concomitants en Colombie-Britannique, au Canada, à partir de données administratives au niveau de la population, entre 2013 et 2021.Can J Psychiatry. 2025 Sep;70(9):667-680. doi: 10.1177/07067437251347150. Epub 2025 Jun 9. Can J Psychiatry. 2025. PMID: 40491188 Free PMC article.
-
Evaluating a mobile app's effects on depression and anxiety in medication-treated opioid use disorder.Npj Ment Health Res. 2024 Sep 30;3(1):43. doi: 10.1038/s44184-024-00086-7. Npj Ment Health Res. 2024. PMID: 39349617 Free PMC article.
References
-
- Centers for Disease Control: Increases in drug and opioid overdose deaths—United States, 2000–2014. Morbidity and Mortality Weekly Report 2016, 64:1378–82. - PubMed
-
- Substance Abuse and Mental Health Services Administration: National Survey on Drug Use and Health 2016.
-
- Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL: Societal costs of prescription opioid abuse, dependence and misuse in the United States. Pain Med 2011, 12: 657–667. - PubMed
-
- Jones CM, Mack K A, Paulozzi LJ: Pharmaceutical overdose deaths, United States. JAMA 2013, 309: 657–659. - PubMed
-
- National Institute of Mental Health: Anxiety Disorders. 2018.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical